# Huixin Lifetech

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/huixin-lifetech

- Industry: Medical Devices & Equipment
- Headquarters: Shenzhen, China
- Website: www.huixinbio.com/
- Total disclosed funding: $14M
- Latest round: Series A (Feb 9, 2026)
- Investors on record: 2

## About

Based in Shenzhen, China, and established in 2017, Shenzhen Huixin Biomedical Technology Co., Ltd., trading as Huixin Lifetech, is a medical equipment developer that provides tumor diagnosis-related products and services. The company has acquired more than 50 patents. In 2020, it was awarded as a small and micro-sized intellectual property advantage enterprise. In February 2026, Huixin Lifetech raised nearly CNY 100 million in series A+ funding led by new investor Legend Capital.

Huixin Lifetech developed automated non-labeled exosome separation and purification technology. As well as it developed exosome detection technology for early cancer diagnosis, based on exosome separation technology. The company's main products include EXODUS automatic exocrine purification system and tumor early screening. EXODUS automatic exosomes purification system removes cells and cell fragments through centrifugation or filtration and then separates and purifies samples.

The company generates revenue by providing fully automated exosome extraction system, cancer detection kits, and MyoYan™ Super Active Exosomes platform.

The company will use the latest funding to accelerate its global business layout, focusing on exosomes and various types of nanoparticles such as viruses and LNPs, building a highly integrated fully automated separation and purification technology platform, achieving a leap from laboratory processes to an industrial-grade intelligent manufacturing system, and continuously promoting the systematic upgrading of cost, efficiency, and quality standards in the fields of biomanufacturing and precision medicine.

## Funding rounds

- Series A, Feb 9, 2026, $14M — Legend Capital
- Angel, Sep 13, 2021 — Co-Win Ventures

## Investors

- Co-Win Ventures (https://capitalatlas.ai/funds/co-win-ventures) — Angel
- Legend Capital — Series A